PATTERN OF NEUROBEHAVIORAL DEFICITS ASSOCIATED WITH INTERFERON-ALFA THERAPY FOR LEUKEMIA

被引：136
|
作者：
PAVOL, MA
MEYERS, CA
REXER, JL
VALENTINE, AD
MATTIS, PJ
TALPAZ, M
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT NEUROONCOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030
来源：
NEUROLOGY | 1995年 / 45卷 / 05期
关键词：
D O I：
10.1212/WNL.45.5.947
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We evaluated the neuropsychological and personality profiles of 25 patients with chronic myelogenous leukemia treated with interferon alfa (IFN-alpha). This group of persons performed well below expectation on tests of cognitive speed, verbal memory, and executive functions. Personality changes included depression, increased somatic concern, and stress reactions. A control group of leukemia patients not treated with IFN-alpha had significantly better cognitive speed and mood. The pattern of cognitive and personality changes in patients receiving IFN-alpha is highly suggestive of frontal-subcortical brain dysfunction.
引用
收藏
页码：947 / 950
页数：4
相关论文
共 50 条
  • [1] Interferon-alfa for chronic myeloid leukemia
    Baccarani, M
    Russo, D
    Rosti, G
    Martinelli, G
    SEMINARS IN HEMATOLOGY, 2003, 40 (01) : 22 - 33
  • [2] INTERFERON-ALFA THERAPY IN AN INFANT WITH JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    TORALDO, R
    VETRANO, F
    PISTOIA, V
    TOLONE, C
    CANINO, G
    DAVANZO, M
    IAFUSCO, F
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1995, 12 (02) : 189 - 194
  • [3] Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy
    Hauschild, Axel
    Kaehler, Katharina C.
    Schaefer, Martin
    Fluck, Michael
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (10): : 829 - 837
  • [4] COMBINATION THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA AND OTHER CYTOKINES
    KLOKE, O
    SEMINARS IN HEMATOLOGY, 1993, 30 (03) : 22 - 23
  • [5] SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH CHRONIC MYELOMONOCYTIC LEUKEMIA - CLINICAL-FEATURES AND RESPONSE TO INTERFERON-ALFA THERAPY
    PETIT, A
    PULIK, M
    GAULIER, A
    LIONNET, F
    MAHE, A
    SIGAL, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (05) : 850 - 853
  • [6] Neuropsychiatric side effects of interferon-alfa therapy
    Van Gool, AR
    Kruit, WHJ
    Engels, FK
    Stoter, G
    Bannink, M
    Eggermont, AMM
    PHARMACY WORLD & SCIENCE, 2003, 25 (01): : 11 - 20
  • [7] REVERSIBLE HYPOPITUITARISM AFTER INTERFERON-ALFA THERAPY
    SAKANE, N
    YOSHIDA, T
    YOSHIOKA, K
    UMEKAWA, T
    KONDO, M
    SHIMATSU, A
    LANCET, 1995, 345 (8960): : 1305 - 1305
  • [8] EVOLVING APPROACHES WITH INTERFERON-ALFA IN CHRONIC MYELOGENOUS LEUKEMIA
    MORRA, E
    ALIMENA, G
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    BERNASCONI, P
    MANCINI, M
    DONTI, E
    MERANTE, S
    CARICCHI, P
    GRIGNANI, F
    BERNASCONI, C
    MANDELLI, F
    SEMINARS IN HEMATOLOGY, 1993, 30 (03) : 26 - 27
  • [9] MYASTHENIA-GRAVIS DURING INTERFERON-ALFA THERAPY
    BATOCCHI, AP
    EVOLI, A
    SERVIDEI, S
    PALMISANI, MT
    APOLLO, F
    TONALI, P
    NEUROLOGY, 1995, 45 (02) : 382 - 383
  • [10] INTERFERON-ALFA THERAPY IN TURKISH PATIENTS WITH BEHCET UVEITIS
    Tugal-Tutkun, Ilknur
    Araz, Bilge
    Aydinoglu-Candan, Ozlem
    Ersan, Mehmet Cemal
    Uludag, Gunay
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S144 - S144
12345